According to a newly published market research report by 24LifeSciences, global Obsessive-Compulsive Disorder (OCD) medicine market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.1 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 2026–2034.
OCD medications are specialized pharmaceuticals used to manage symptoms...